London
· Delayed Price · Currency is GBP · Price in GBXProteome Sciences Statistics
Total Valuation
Proteome Sciences has a market cap or net worth of GBP 8.21 million. The enterprise value is 20.62 million.
| Market Cap | 8.21M |
| Enterprise Value | 20.62M |
Important Dates
The last earnings date was Monday, November 25, 2024.
| Earnings Date | Nov 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Proteome Sciences has 295.18 million shares outstanding. The number of shares has decreased by -2.77% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 295.18M |
| Shares Change (YoY) | -2.77% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.93% |
| Owned by Institutions (%) | 23.82% |
| Float | 185.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.06 |
| EV / Sales | 5.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.66 |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.38 |
| Interest Coverage | -3.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.25% |
| Return on Capital (ROIC) | -21.66% |
| Revenue Per Employee | 115,286 |
| Profits Per Employee | -116,514 |
| Employee Count | 35 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 4.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.44% |
| 50-Day Moving Average | 2.74 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 53.72 |
| Average Volume (20 Days) | 224,285 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Proteome Sciences had revenue of GBP 4.04 million and -4.08 million in losses. Loss per share was -0.01.
| Revenue | 4.04M |
| Gross Profit | 85,000 |
| Operating Income | -3.16M |
| Pretax Income | -4.02M |
| Net Income | -4.08M |
| EBITDA | -2.90M |
| EBIT | -3.16M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.21 million in cash and 13.62 million in debt, giving a net cash position of -12.41 million or -0.04 per share.
| Cash & Cash Equivalents | 1.21M |
| Total Debt | 13.62M |
| Net Cash | -12.41M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -5.27M |
| Book Value Per Share | -0.02 |
| Working Capital | -10.62M |
Cash Flow
In the last 12 months, operating cash flow was -1.92 million and capital expenditures -219,000, giving a free cash flow of -2.13 million.
| Operating Cash Flow | -1.92M |
| Capital Expenditures | -219,000 |
| Free Cash Flow | -2.13M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 2.11%, with operating and profit margins of -78.41% and -101.07%.
| Gross Margin | 2.11% |
| Operating Margin | -78.41% |
| Pretax Margin | -99.60% |
| Profit Margin | -101.07% |
| EBITDA Margin | -71.85% |
| EBIT Margin | -78.41% |
| FCF Margin | n/a |
Dividends & Yields
Proteome Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.77% |
| Shareholder Yield | 2.77% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Proteome Sciences has an Altman Z-Score of -12.53. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.53 |
| Piotroski F-Score | n/a |